What risk/pathologic factors merit PMRT for a patient with recurrent breast cancer and a prior history of ipsilateral breast irradiation?  

If the patient has evidence of axillary lymphadenopathy on imaging, would that change your approach to treatment? 

Would response to neoadjuvant chemotherapy change your decision making process? 



Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Academic Institution